Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,501-16,512 of 23,847
Drug study icon
CompletedNCT06527885

Lurasidone Non-Interventional Study in Schizophrenia Patients

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

Multiple locations, including Brescia
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 99 Years
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Condition
Schizophrenia
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Dothan
Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01620060

Lurasidone Pediatric Pharmacokinetics Study

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Biological study icon
CompletedNCT05204407

Luteolin for People With Schizophrenia

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Los Angeles
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Behavioral study icon
WithdrawnNCT04281719

M-Health for Teen Substance Abuse and Mental Illness

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Addiction, PTSDBehavioralFrom 14 Years to 17 Years
Countries
Sponsor
Indiana University
Condition
Addiction, PTSD
Drug study icon
CompletedNCT05105542

M1 Schizophrenia PET Study

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

In New Haven
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT03482466

Machine Learning Neurofeedback for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
PTSDBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Drug study icon
Active Not RecruitingNCT07458022

MAGNESIUM & SSRI VS SSRI ALONE AMONG PATIENTS OF MAJOR DEPRESSIVE DISORDER

This study is looking at whether Use of magnesium with SSRI can help people with Major Depressive Diorder. Participants take part in Use of magnesium with SSRI and complete follow-up assessments.

In Multan
DepressionDrugOver 18 Years
Countries
Pakistan
Sponsor
University of Child Health Sciences and Children's Hospital, Lahore
Condition
Depression
Behavioral study icon
CompletedNCT07521358

Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression

This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Makassar
DepressionBehavioralFrom 18 Years to 60 Years
Countries
Indonesia
Sponsor
Hasanuddin University
Condition
Depression
Device study icon
CompletedNCT04842929

Magnetic study in Elderly Depressed

This study is completed in Brazil. It focuses on Depression.

In São Paulo
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 60 Years
Countries
Brazil
Sponsor
University of Sao Paulo
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.